174 related articles for article (PubMed ID: 36889164)
1. Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation.
Yang T; Wang Y; Cao X; Peng Y; Huang J; Chen L; Pang J; Jiang Z; Qian S; Liu Y; Ying C; Wang T; Zhang F; Lu Q; Yin X
Phytomedicine; 2023 May; 113():154703. PubMed ID: 36889164
[TBL] [Abstract][Full Text] [Related]
2. YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation.
Yang T; Hu Y; Jiang W; Pang J; Zhou Y; Zhang H; Yin Z; Jiang Z; Qian S; Wei C; Yan M; Zhu X; Wang T; Lu Q
Phytomedicine; 2023 Mar; 111():154659. PubMed ID: 36641979
[TBL] [Abstract][Full Text] [Related]
3. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice.
Yang H; Yang T; Heng C; Zhou Y; Jiang Z; Qian X; Du L; Mao S; Yin X; Lu Q
Phytother Res; 2019 Dec; 33(12):3140-3152. PubMed ID: 31452288
[TBL] [Abstract][Full Text] [Related]
4. The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice.
Yan X; Zhang Y; Peng Y; Li X
J Ethnopharmacol; 2022 Jul; 293():115238. PubMed ID: 35351576
[TBL] [Abstract][Full Text] [Related]
5. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.
Li T; Francl JM; Boehme S; Chiang JY
Hepatology; 2013 Sep; 58(3):1111-21. PubMed ID: 23536474
[TBL] [Abstract][Full Text] [Related]
7. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Enterohepatic Bile Acid Signaling Induces Hepatic Autophagy via a CYP7A1-AKT-mTOR Axis in Mice.
Wang Y; Ding Y; Li J; Chavan H; Matye D; Ni HM; Chiang JY; Krishnamurthy P; Ding WX; Li T
Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):245-260. PubMed ID: 28275691
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
[TBL] [Abstract][Full Text] [Related]
11. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.
Qi Y; Jiang C; Cheng J; Krausz KW; Li T; Ferrell JM; Gonzalez FJ; Chiang JY
Biochim Biophys Acta; 2015 Jan; 1851(1):19-29. PubMed ID: 24796972
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
13. Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats.
Zhang M; Xie Z; Gao W; Pu L; Wei J; Guo C
Nutr Res; 2016 Mar; 36(3):271-9. PubMed ID: 26923514
[TBL] [Abstract][Full Text] [Related]
14. Novel ι-Carrageenan Tetrasaccharide Alleviates Liver Lipid Accumulation via the Bile Acid-FXR-SHP/PXR Pathway to Regulate Cholesterol Conversion and Fatty Acid Metabolism in Insulin-Resistant Mice.
Li Y; Tian Y; Cai W; Wang Q; Chang Y; Sun Y; Dong P; Wang J
J Agric Food Chem; 2021 Sep; 69(34):9813-9821. PubMed ID: 34415766
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
Liu H; Pathak P; Boehme S; Chiang JL
J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
[TBL] [Abstract][Full Text] [Related]
16. Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.
Park WH; Pak YK
Exp Mol Med; 2011 Oct; 43(10):571-9. PubMed ID: 21817852
[TBL] [Abstract][Full Text] [Related]
17. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
[TBL] [Abstract][Full Text] [Related]
18. Regulation effects of total flavonoids in Morus alba L. on hepatic cholesterol disorders in orotic acid induced NAFLD rats.
Hu Y; Xu J; Chen Q; Liu M; Wang S; Yu H; Zhang Y; Wang T
BMC Complement Med Ther; 2020 Aug; 20(1):257. PubMed ID: 32807146
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
20. Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF.
Zhong D; Xie Z; Huang B; Zhu S; Wang G; Zhou H; Lin S; Lin Z; Yang B
Cell Physiol Biochem; 2018; 49(3):1163-1179. PubMed ID: 30196282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
